: Full FDA approval of Pfizer’s and Moderna’s COVID-19 shots would reinvigorate the U.S. vaccination push — but it could still be months away
The "full" approval of Pfizer and Moderna's COVID-19 vaccines sometime this year could boost sagging vaccination rates in the U.S., though the Food and Drug Administration's decision may not happen until the end of the year.

from MarketWatch.com - Top Stories https://ift.tt/3qvtYhn
via IFTTT
from MarketWatch.com - Top Stories https://ift.tt/3qvtYhn
via IFTTT
Kommentare
Kommentar veröffentlichen